Your Article Summary
See Latest ArticlesInsulin Analogs versus Human Insulin in the Treatment of Patients with Diabetic Ketoacidosis: a randomized controlled trial
Diabetes Care, 07/02/09
Umpierrez GE et al. - Regular and glulisine insulin are equally effective during the acute treatment of DKA. Transition to SC glargine and glulisine following resolution of DKA resulted in similar glycemic control but in a lower rate of hypoglycemia than NPH and regular insulin. Thus, a basal bolus regimen with glargine and glulisine is safer and should be preferred over NPH and regular insulin following the resolution of DKA.
Related Articles
Paediatric diabetic ketoacidosis
Continuing Education in Anaesthesia, Critical Care & Pain, 11/18/09
Relevance Score: 85%
Diabetes Complication Causes Memory Problems
Ivanhoe, 10/26/09
Relevance Score: 84%
Diabetic Episodes Affect Kids Memory
ScienceDaily, 10/21/09
Relevance Score: 80%
Diabetic episodes affect kids memory
EurekAlert, 10/20/09
Relevance Score: 80%
Diabetic Ketoacidosis and Memory Dysfunction in Children with Type 1 Diabetes
The Journal of Pediatrics, 10/16/09
Relevance Score: 80%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09